2021 China New Design Cisatracurium Besylate - Sorafenib CAS 284461-73-0 Purity ≥99.0% (HPLC) API High Quality – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

Our intention should be to fulfill our consumers by offering golden provider, superior price and superior quality for 83150-76-9, Atorvastatin Calcium Intermediate L-1, Weight 206.19, While using the improvement of society and economy, our corporation will retain a tenet of "Focus on trust, high quality the first", moreover, we count on to make a glorious long run with each and every customer.

2021 China New Design Cisatracurium Besylate - Sorafenib CAS 284461-73-0 Purity ≥99.0% (HPLC) API High Quality – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Commercial Supply Sorafenib Tosylate (CAS: 475207-59-1) Related Intermediates:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4-(4-Aminophenoxy)-N-Methyl-2-Pyridinecarboxamide CAS: 284462-37-9
4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS: 327-78-6

Name	Sorafenib
Synonyms	Sorafenib Free Base
CAS Number	284461-73-0
CAT Number	RF-API04
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C21H16ClF3N4O3
Molecular Weight	464.82
Brand	Ruifu Chemical

Item	Specifications
Appearance	White to Off-White Powder
Purity / Analysis Method	≥99.0% (HPLC)
Identification	H-NMR, MS
Loss on Drying	≤1.0%
Residue on Ignition	≤0.1%
Single Impurity	≤0.2% (HPLC)
Total Impurities	≤1.0% (HPLC)
Test Standard	Enterprise Standard
Usage	Sorafenib Tosylate (CAS: 475207-59-1)

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Sorafenib Tosylate (CAS: 475207-59-1) is a new type of multi-target antitumor drug, was developed by the German Bayer Pharmaceuticals, and displayed expansive antitumor activity in preclinical animal tests. Sorafenib is available in 200-mg tablets for oral administrationand is used in the treatment of RCC and HCC. Sorafenib Tosylate (CAS: 475207-59-1) can simultaneously affect tumor cells and tumor blood vessels. It has a double antitumor effect: it can block the cell signal transduction pathways mediated by RAF/MEK/ERK to directly inhibit tumor cell growth, while also inhibiting VEGF and platelet derived growth factors (PDGF) receptors to prevent the formation of new tumor blood vessels, thus indirectly inhibiting tumor cell growth. Sorafenib Tosylate (Bay 43-9006) is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with IC50 of 6 nM, 22 nM and 90 nM, respectively.

Product detail pictures:

Related Product Guide:

The company keeps to the operation concept "scientific management, high quality and efficiency primacy, customer supreme for 2021 China New Design Cisatracurium Besylate - Sorafenib CAS 284461-73-0 Purity ≥99.0% (HPLC) API High Quality – Ruifu , The product will supply to all over the world, such as: Slovakia, Swedish, Honduras, The development of our company not only needs the guarantee of quality, reasonable price and perfect service, but also relies on our customer's trust and support! In the future, we will continue with the most professional and high quality service to provide the most competitive price, Together with our customers and achieve win-win! Welcome to inquiry and consult!